Medi-Tech Insights Get in touch

Biologics Market Size, Share, Industry Demand, Growth and Analysis for Forecast 2024 to 2029

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2023-2024)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Biologics Market Snapshot (2023-2029)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights

  • Growing investment in biopharmaceutical R&D
  • Growing strategic partnerships between biotech & larger pharmaceutical companies
  • Restraints
    • High production costs
    • Stringent regulatory requirements
    • Competition from small molecule drugs and generics
  • Opportunities
    • Personalized medicine
    • Biosimilars
    • Emerging therapeutic applications
  • Key Market Trends
    • Advanced biomanufacturing technologies
    • Cell and gene therapies
  • Unmet Market Needs
  • Industry Speaks
  • Pipeline Analysis
  • Regulatory Analysis
    1. Global Biologics Market Size & Forecast (2022-2029), By Product, USD Million
      • Introduction
      • Keytruda
      • Comirnaty
      • Humira
      • Eylea
      • Dupixent
      • Stelara
      • Others
    2. Global Biologics Market Size & Forecast (2022-2029), By Modality, USD Million
      • Introduction
      • Monoclonal Antibodies
      • Vaccines
      • Recombinant Proteins
      • Cell and Gene Therapies
      • Others
    3. Global Biologics Market Size & Forecast (2022-2029), By Type, USD Million
      • Introduction
      • Innovative
      • Generic/Biosimilars
    4. Biologics Market Size & Forecast (2022-2029), By Manufacturing, USD Million
      • Introduction
      • In-house/Captive Manufacturing
      • Outsourced/Merchant Manufacturing
      • Others
    5. Biologics Market Size & Forecast (2022-2029), By Indication, USD Million
      • Introduction
      • Oncology
      • Infectious Diseases
      • Immunological Disorders
      • Cardiovascular Disorders 
      • Respiratory Disorders 
      • Others​ 
    6. Global Biologics Market Size & Forecast (2022-2029), By Region, USD Million
    • Introduction
    • North America Biologics Market Size & Forecast (2022-2029), By Country, USD Million
      • US
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Canada
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    • Europe Biologics Market Size & Forecast (2022-2029), By Country, USD Million
      • UK
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Germany
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • France
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Italy
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Spain
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Rest of Europe
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    • Asia Pacific (APAC) Biologics Market Size & Forecast (2022-2029), By Country, USD Million
      • China
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Japan
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • India
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    • Latin America (LATAM) Biologics Market Size & Forecast (2022-2029), USD Million
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    • Middle East & Africa (MEA) Biologics Market Size & Forecast (2022-2029), USD Million
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Modality (USD Million)
        • Market Size & Forecast, By Type (USD Million)
        • Market Size & Forecast, By Manufacturing (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    1. Competitive Landscape
      • Key Players and their Competitive Positioning
        • Key Player Comparison
        • Segment-wise Player Mapping
        • Market Share Analysis (2023)
        • Company Categorization Matrix
          • Dominants/Leaders
          • New Entrants
          • Emerging Players
          • Innovative Players
        • Key Strategies Assessment, By Player (2022-2024)
          • New Product Launches
          • Partnerships, Agreements, & Collaborations
          • Mergers & Acquisitions
          • Geographic Expansion
    1. Company Profiles*

    (Business Overview, Financial Performance**, Products Offered, Recent Developments)

    • AbbVie Inc.
    • Amgen Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi
    • Other Prominent Players

    Related Reports

    View All Research Reports